The gut microbiome-bile acid axis in hepatocarcinogenesis.

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is a leading cause of cancer-related deaths globally, with few effective therapeutic options. Bile acids (BAs) are synthesized from cholesterol in the liver and can be modulated by farnesoid X receptor (FXR) and G-protein coupled BA receptor 1 (GPBAR1/TGR5). Alterations in BAs can affect hepatic metabolic homeostasis and contribute to the pathogenesis of liver cancer. Increasing evidence points to the key role of bacterial microbiota in the promotion and development of liver cancer. They are also involved in the regulation of BA synthesis and metabolism. The purpose of this review is to integrate related articles involving gut microbiota, BAs and HCC, and review how the gut microbiota-BA signaling axis can possibly influence the development of HCC. Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Citation

Liwei Wu, Jiao Feng, Jingjing Li, Qiang Yu, Jie Ji, Jianye Wu, Weiqi Dai, Chuanyong Guo. The gut microbiome-bile acid axis in hepatocarcinogenesis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2021 Jan;133:111036

Mesh Tags

Substances

PMID: 33378947

search → result